Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

Chiara Camisaschi, Viviana Vallacchi, Chiara Castelli, Licia Rivoltini, Monica Rodolfo

Research output: Contribution to journalArticle

Abstract

Melanoma is an immunogenic tumor and immunotherapy treatment has established an increase in disease-free and overall survival in melanoma patients. However, a complex network of immunosuppressive mechanisms has been demonstrated to occur at the tumor site and in locoregional immune districts, such as sentinel lymph nodes (SLNs). The interplay between tumor cells and the local microenvironment leads to a tumor-driven shaping of the immune response that results in a heterogeneous cellular and molecular composition of tumor infiltrating lymphocytes (TILs). Several studies have reported the potential prognostic value of TILs infiltrating primary tumors and the association of 'immune signature' in SLNs and in melanoma metastases with prognosis and responsiveness to immunotherapeutic approaches. However, a systematic and deeper characterization of the local immunological status of TILs and SLNs is still required to refine melanoma stage classification.

Original languageEnglish
Pages (from-to)643-646
Number of pages4
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number6
DOIs
Publication statusPublished - 2014

Keywords

  • Immunotherapy
  • Melanoma
  • Prognosis
  • Sentinel node
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment'. Together they form a unique fingerprint.

  • Cite this